Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1047 of 1,261
  1. US 7452681

    Diagnostic methods for the detection of autism spectrum disorder

    The Regents of the University of California · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  2. US 7452538

    Death domain containing receptor 4 antibodies and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  3. US 7452971

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  4. US 7452723

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  5. WO 2008137828

    MODÈLE DE MARQUEUR DE MATRICE ET PROCÉDÉS POUR ÉVALUER ET TRAITER L'ARTHRITE ET DES TROUBLES ASSOCIÉS

    CENTOCOR INC [US] · Granted Nov 13, 2008 · Expires Nov 8, 2028

    granted
  6. US 7449557

    Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

    University of Connecticut Health Center · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  7. US 7449444

    Hydroxyethyl starch-containing polypeptide compositions

    The Regents of the University of Colorado · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  8. US 7449458

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  9. US 7449201

    Storage stable power compositions of interleukin-4 receptor

    Nektar Therapeutics · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  10. US 7449192

    Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

    The Regents of the University of Colorado · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  11. US 7449182

    Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  12. US 7449171

    Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products

    The Regents of the University of California · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  13. US 7449190

    Assays for assembly of Ebola virus nucleocapsids

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  14. US 7449570

    Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

    PTC THERAPEUTICS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  15. US 7449202

    Compositions and methods for prostate and kidney health and disorders, an herbal preparation

    Integrated Chinese Medicine Holdings Ltd. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  16. US 7449323

    Hemorrhagic feline calicivirus

    The Regents of the University of California · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  17. US 7445890

    Ucp-2 promoter and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  18. US 7446199

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  19. US 7446182

    Recombinant antibodies for the detection and neutralization of anthrax toxin

    The Board of Regents of the University of Texas System · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  20. US 7446114

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  21. US 7446124

    Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  22. US 7446108

    Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists

    Neurocrine, Inc. · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  23. US 7446112

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  24. US 7445628

    Method of treating a patient with a coated implantable medical device

    Cook Regentec LLC · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.